Alto Neuroscience Inc.

ANRO XNYS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

660M

Short interest (May 15)

4.6%

Net Short (Jun 03 ): -0.1%

Borrow Fee

0.69%

↓ 32.5%

Available Shares

↑ 13.6%

Price Chart

Company Overview

Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-207, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.

Company Info

Exchange: NYSE

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001999480

Asset Type: CS

Market Data

Market Cap: $656,607,617

Employees: 68

Status: Active

Short Interest

Current Borrow Fee 0.69%

Range: 0.69% - 1.08%

Available Shares 1M

Range: 1M - 1.1M

Recent Changes

Fee Change: ↓ 20.0%

Available Change: ↑ 4.8%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime